Hims Hers Health Inc (HIMS)

$30.02 -$0.31 (-1.03%) 4:38 PM 12/13/24
NYSE | $USD | Household & Personal Products

Stock Data

  • Market Cap

    $7.48B
  • Day's Range

    $28.40 - $30.60
  • Volume

    16,505,010
  • 52 Week Low / High

    $8.09 - $35.02
  • PE Ratio

    77.80x
  • PEG Ratio

    -
  • Dividend Frequency

    -

HIMS's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
3
Strong Buy
2
Buy
7
Hold
1
Sell
0
Strong Sell
$12.30
Target Price

Company News

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024

    As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024

    As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024

    As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024

    As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...

  • Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024

    Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024

    Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024

    As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...

  • Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024

    Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024

    Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....

  • Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024

    Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....

  • Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

    On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

  • Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024

    Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...

Similar Stocks

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free